You tried the first stimulant, then the second, then a third. Maybe the side effects were too much, maybe it wore off by lunchtime, maybe the anxiety got worse or the mood changed. Families in this position often start to wonder whether ADHD medication simply doesn't work for their child, or whether the diagnosis was wrong in the first place. Both questions are fair, and both deserve a structured answer.
One important note before anything else: do not stop or change a prescribed medication abruptly on your own. Talk with the prescriber first, and call right away if there is chest pain, fainting, hallucinations, severe agitation or any thoughts of self-harm.
Failing three stimulants is not a verdict
Stimulants are the most effective medications we have for ADHD, but response is individual. The AACAP practice parameter on stimulant medications reports that about 70% of children respond to either methylphenidate or amphetamine alone, and that nearly 90% respond when both are tried, although some of those children have side effects they can't tolerate. The AAP's 2019 guideline describes the same variability: roughly 40% of patients respond to both medication classes and about 40% to only one. Similar figures appear in clinical reviews, which put the stimulant response rate in school-age children at roughly 70% to 75%.
Two practical points follow. First, it matters whether the three medications were truly different. Three formulations of the same class is not the same as having tried both methylphenidate-based and amphetamine-based medications. Second, "not working" often means the problem lies elsewhere: the dose, the timing, the diagnosis, or something else going on alongside ADHD.
Side effects that lead families to stop
Decreased appetite and weight loss
Stomachaches and headaches
Trouble falling asleep
Irritability or emotional swings, especially as the dose wears off
Jitteriness, restlessness or worsening anxiety
Low mood, tearfulness, or feeling flat or "not like themselves"
New or worse tics
Faster heart rate or higher blood pressure
Slowed growth. The AAP reports an average of about 1 to 2 cm below predicted adult height, which diminishes by the third year
Rarely, hallucinations or other psychotic symptoms, which need prompt medical attention
Some of these can be fixed with a lower dose, a different release profile, a change in timing, or dosing with food. Others are a signal to rethink the plan, particularly worsening anxiety or mood, which can mean the stimulant is unmasking or aggravating another condition, or that ADHD is not the whole picture.
"It doesn't last long enough"
When a dose wears off too early, the cause is usually the formulation or the timing, not the child. Shorter-acting forms can leave gaps, and a rebound of irritability or restlessness as the medication fades is common. Options include a longer-acting preparation, adjusting the time of day, or in some cases adding a small second dose, with the trade-off that later dosing can affect sleep. This is a conversation to have with the prescriber, with notes on exactly when the benefit starts and ends.
Common reasons treatment seems to fail
The diagnosis is incomplete or wrong. Anxiety, depression and other conditions can look like ADHD.
Other conditions are present. Anxiety, depression, learning disorders, autism, tics, sleep problems, trauma and, in teens and young adults, substance use are common alongside ADHD and can limit the response.
The dose was never fully optimized. Starting doses are often low, and titration may stop before the best dose is found. The opposite problem happens too: a dose that is too high can cause the very side effects that end the trial.
Adherence. One review reported discontinuation of about 19% with long-acting and 38% with short-acting stimulants. Side effects are a leading reason.
Sleep, school and home factors. Poor sleep, a major life change, family stress or an unmanageable classroom setting can all blunt a medication's effect.
Expectations. Medication can improve attention and impulse control. It does not teach organization, study skills or emotional coping, which usually need direct support.
Time to reevaluate: starting fresh
When first-line treatment has not worked, the AAP guideline's own steps apply: reassess the diagnosis, screen again for coexisting conditions, check the dose and adherence, and add behavioral support. In practice, a fresh evaluation looks like this:
Confirm that DSM-5 criteria are met: symptoms present before age 12, in more than one setting, with real impairment
Take a new developmental history, including birth and early-life factors, trauma, family history and sleep
Gather input from teachers and other adults, and repeat validated rating scales
Create a timeline of every medication tried: the dose, how long, the formulation and what happened
Use objective attention testing such as QbCheck when it will add information, never as the only basis for a diagnosis
What to rule out
Anxiety. Can look like restlessness, poor concentration and irritability, and stimulants can make it worse.
Depression. Poor concentration and fidgeting can mimic ADHD, and mood often declines on stimulants if depression is present.
Bipolar disorder. Stimulants can destabilize mood in some patients. Look for distinct episodes of elevated or irritable mood with decreased need for sleep, and a family history of bipolar disorder.
Autism spectrum disorder. Inattention and emotional dysregulation can be part of autism, and medication response may differ.
Learning disorders. A child who can't read or process language efficiently will look inattentive no matter what medication they take.
Sleep disorders. Insomnia, delayed sleep phase and sleep apnea all produce daytime inattention.
Trauma and tics. Trauma-related symptoms resemble ADHD, and tics can appear or worsen on stimulants.
Medical contributors. Examples include thyroid problems, vision or hearing problems and seizure disorders.
Substance use. Particularly relevant for teens and young adults.
Medication options beyond the first three
These are decisions for the prescriber, but it helps to know the landscape:
Optimize what has been tried: dose, formulation and timing
Try the other stimulant class if only one has been used
Nonstimulants: atomoxetine, extended-release guanfacine and extended-release clonidine are FDA-approved for school-age children and adolescents. Their effects are generally smaller than stimulants (the AAP cites effect sizes of about 0.7 versus about 1.0), but they can be a better fit when stimulants are not tolerated or when anxiety, tics or sleep are issues. Atomoxetine carries an FDA boxed warning for suicidal thoughts, so mood needs close monitoring. Guanfacine and clonidine should be tapered, not stopped suddenly.
Add-on treatment: extended-release guanfacine or clonidine are FDA-approved as add-ons to a stimulant
Treat the coexisting condition with therapy, medication or both, often first
For transparency, the AAP currently does not recommend pharmacogenetic testing for choosing ADHD medication. It can be useful for specific medication-safety questions, but it won't tell us which ADHD medicine will work.
When testing helps: psychoeducational and neuropsychological evaluation
ADHD is diagnosed clinically. Testing does not replace that, but it can find what the medication was never going to fix.
Psychoeducational testing measures intellectual ability and academic skills, and identifies learning disorders such as dyslexia. It is often done through the school and supports an IEP or 504 plan.
Neuropsychological testing is broader and covers memory, processing speed, language and executive function. It is most useful when the picture is complex: poor response despite adequate medication trials, diagnostic uncertainty, a history of prematurity, seizures or head injury, or suspected autism or learning disorder.
How it fits by age:
Elementary school: Request a school evaluation in writing if learning or behavior is affecting progress. Academic gaps matter most at this age.
Middle and high school: Testing can document the need for accommodations and clarify why grades don't match ability. Recent testing is often required for exam and college accommodations, and requirements vary.
College and young adults: Testing is usually private and is used to document needs for the campus disability services office.
What to do now at home and at school
Keep a simple daily log of focus, mood, appetite, sleep and side effects by time of day, for two weeks
Ask the school for a meeting, and request teacher rating scales and examples of where your child is struggling
Protect sleep, schedule breakfast and daily physical activity, and keep routines predictable
Ask about parent training in behavior management (which the AAP supports for younger children), organizational skills coaching, and therapy for anxiety or mood if those are present
Bring the medication timeline, past testing and school reports to the next visit
When to seek a psychiatric nurse practitioner or specialist
Primary care clinicians manage ADHD every day, and many do it well. The AAP expects pediatricians to manage mild-to-moderate ADHD and to refer or co-manage when a coexisting condition is beyond their training or when the case is complex. Consider a specialist if:
Two or more medication trials have failed or caused intolerable side effects
The diagnosis is uncertain, or ADHD may not be the main problem
Anxiety, depression, mood swings, tics or irritability have appeared or worsened on medication
Your child takes more than one psychiatric medication, or the regimen keeps growing
There are safety concerns such as self-harm, psychosis or mania
You want a second opinion on the diagnosis or plan
Why a specialist? A psychiatric nurse practitioner or child psychiatrist can take more time for a full reassessment, is trained to sort out overlapping conditions, and is comfortable with the second- and third-line options and combinations. This is not about replacing your pediatrician. The best arrangement is usually a partnership, with the specialist directing the medication plan and keeping the pediatrician informed.
At SHIELD Psychiatry, Dr. Akers is a board-certified psychiatric mental health nurse practitioner and a board-certified pediatric primary care nurse practitioner. We offer ADHD reevaluations and second-opinion evaluations by secure telehealth throughout Florida, with in-person visits in Lutz. Start a pre-screen, call (813) 592-7228, or read about our ADHD evaluations, QbCheck testing and psychiatric evaluations.
Dr. Marie Akers, DNP, APRN, PMHNP-BC, PPCNP-BC, is a psychiatric mental health nurse practitioner and the founder of SHIELD Psychiatry in Lutz, Florida. This article is general education and is not a substitute for individual medical advice. Do not change prescribed medication without speaking to your prescriber.
